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Inhibitor of DNA binding/differentiation 2 induced by hypoxia
promotes synovial fibroblast-dependent osteoclastogenesis
Abstract
OBJECTIVE: To map hypoxic areas in arthritic synovium and to establish the relevance of low oxygen
levels to the phenotype of synovial fibroblasts, with special focus on bone degradation. METHODS: To
analyze the distribution of hypoxia in arthritic joints, the hypoxia marker EF5 was administered to mice
with collagen-induced arthritis (CIA). To evaluate the effect of hypoxia on rheumatoid arthritis synovial
fibroblasts (RASFs), reverse suppression subtractive hybridization and complementary DNA array were
used. Real-time polymerase chain reaction, Western blotting, and immunohistochemistry were used to
evaluate the expression of inhibitor of DNA binding/differentiation 2 (ID-2). To investigate the function
of ID-2 in RASFs, cells were transfected either with ID-2 vector or with ID-2-specific small interfering
RNA. RESULTS: EF5 staining showed the presence of hypoxia in arthritic joints, particularly at sites of
synovial invasion into bone. Differential expression analysis revealed that ID-2 was strongly induced by
hypoxia in RASFs. Immunohistochemical analysis of CIA mouse synovium and human RA synovium
showed a strong expression of ID-2 by RASFs at sites of synovial invasion into bone. Overexpression of
ID-2 in RASFs significantly induced the expression of several factors promoting osteoclastogenesis.
The biologic relevance of the potent osteoclastogenesis-promoting effects was shown by coculture
assays of ID-2-overexpressing RASFs with bone marrow cells, leading to an increased differentiation of
osteoclasts from bone marrow precursors. CONCLUSION: The data show that hypoxic conditions are
present at sites of inflammation and synovial invasion into bone in arthritic synovium. Hypoxia-induced
ID-2 may contribute to joint destruction in RA patients by promoting synovial fibroblast-dependent
osteoclastogenesis.
Id-2 induced by hypoxia promotes synovial fibroblast-dependent 
osteoclastogenesis  
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Abstract 
Objective: The aim of our study was to map hypoxic areas in the arthritic synovium and to 
establish the relevance of low oxygen levels to the phenotype of synovial fibroblasts with special 
focus on bone degradation.  
Methods: To analyze the distribution of hypoxia in arthritic joints, the hypoxia marker EF-5 was 
administered to mice with collagen-induced arthritis (CIA). To evaluate the effect of hypoxia on 
rheumatoid arthritis synovial fibroblasts (RASF), reverse subtractive hybridisation and cDNA 
array were used. Real-time PCR, Western blot, and immunohistochemistry were used to evaluate 
the expression of inhibitor of differentiation-2 (Id-2). To look at the function of Id-2 in RASF, 
cells were either transfected with Id-2 vector or Id-2 specific siRNA. 
Results: EF-5 staining showed the presence of hypoxia in arthritic joints, particularly at sites of 
synovial invasion into bone. Differential expression analysis revealed that Id-2 is strongly 
induced by hypoxia in RASF. Immunohistochemistry on CIA and human RA synovium showed 
a strong expression of Id-2 by RASF at sites of synovial invasion into bone. Overexpression of 
Id-2 in RASF significantly induced the expression of several factors promoting 
osteoclastogenesis. The biological relevance of the potent osteoclastogenesis-promoting effects 
was shown by co-culture assays of Id-2 overexpressing RASF with bone marrow cells leading to 
an increased differentiation of osteoclasts from bone marrow precursors.  
Conclusion: The data show that hypoxic conditions are present at sites of inflammation and 
synovial invasion into bone in arthritic synovium. Hypoxia induced Id-2 may contribute to joint 
destruction in RA patients by promoting synovial fibroblast-dependent osteoclastogenesis. 
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Introduction 
A number of studies have suggested that the microenvironment of the rheumatoid 
synovium is ischemic and hypoxic (1). This hypothesis is supported by the analysis of the 
oxygen tension in the synovial fluid, which demonstrated that the mean oxygen levels in patients 
with rheumatoid arthritis (RA) are reduced compared to healthy controls. In addition, indirect 
markers of hypoxia have been found in the RA synovium including an increased level of lactate 
together with acidosis (2).  
In general, the expression of hypoxia-regulated genes is mediated by a highly conserved 
transcription factor called hypoxia inducible factor (HIF), which consists of one of the hypoxia 
stabilized alpha subunits (HIF-1α, HIF-2αHIF-3α) and an ubiquitously expressed beta subunit 
(HIF-1β) (1). HIF-1α is expressed in RA synovial biopsies, but not in synovial biopsies from 
patients with osteoarthritis (OA) (3). Moreover, data obtained by Cramer et al. provide a strong 
link between hypoxia signaling and synovial inflammation (4). However, the relevance of low 
oxygen levels to joint destruction (one of the key features of RA) has not been addressed.  
The inhibitor of differentiation (Id-2) is a member of the helix-loop-helix (HLH) protein 
family (Id 1-4) forming high-affinity heterodimers with basic HLH transcription factors (bHLH). 
Id proteins lack a basic amino acid domain and are therefore unable to bind to DNA. Binding of 
Id proteins to bHLH inhibits dimerization of bHLH with other transcription factors, thereby 
leading to the inhibition of the transcription of specific genes driven by bHLH (5). The 
interaction of Id-2 with bHLH transcription factors plays a critical role in determining cell 
lineage and cell phenotype (6-10).  
In this study, we used the hypoxia marker EF-5, which is well established for the 
detection of hypoxia in tumors (11), to analyze the presence and distribution of hypoxic sites in 
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the collagen-induced arthritis model of RA. We showed that hypoxic cells can be found in 
inflammatory infiltrates and at sites of synovial invasion into bone. We identified the inhibitor of 
differentiation (Id-2) as a downstream molecule of hypoxia in synovial fibroblasts. Consistent 
with the distribution of hypoxia in synovium, Id-2 was strongly expressed by synovial fibroblasts 
at sites of invasion into bone in synovial biopsies from patients with RA. Functional co-culture 
experiments with Id-2 transfected cells showed that overexpression of Id-2 in synovial 
fibroblasts significantly promotes the differentiation of osteoclasts from bone marrow precursors. 
Taken together, these data suggest that Id-2 induced by hypoxia at sites of synovial invasion into 
bone may trigger bone destruction by fibroblast-dependent osteoclastogenesis in RA.  
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Material and Methods 
Patients  
Synovial tissue specimens and bone marrow cells were obtained during synovectomy and 
arthroplastic surgery from consented patients with RA, OA, and from trauma patients (Clinic of 
Orthopedic Surgery, Schulthess Hospital, Zurich). The study protocol was approved by the local 
ethics committees. 
 
Collagen induced arthritis  
CIA was induced by immunising male DBA/1 mice (8-10 weeks old) by intradermal injection of 
150 g of chicken collagen type II (Sigma-Aldrich, St. Louis, MO) emulsified in complete 
Freund’s adjuvant (CFA, Sigma). Mice were then challenged with 150 g of collagen II in CFA 
on day 21 (12). Control group received an injection of PBS. DBA/1 mice were bred and housed 
at the animal facility of the Institute of Rheumatology, Warsaw, Poland. 
 
Administration of EF-5 
The hypoxia marker, EF-5 (Radiation Oncology Imaging Service Center, University of 
Pennsylvania, PE, USA) was administered intraperitoneally to CIA mice and control mice 14 
days after the second immunization (10 l of 10 mM EF-5 in 0.9% saline / g body weight) (13). 
In viable, hypoxic cells but not in necrotic cells, EF-5 is biochemically reduced to a product that 
binds covalently to thiols of proteins (11). Specific monoclonal antibodies (ELK3-51, University 
of Pennsylvania) recognizing adducts of EF-5 in cells allow its detection (11). Four hours after 
the injection, all mice were sacrificed and paws were snap-frozen and store at -80 0C for further 
analysis.  All animal experiments in this study were carried out in accordance with the Polish 
Home Office guidelines. 
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Cell cultures 
Human synovial fibroblasts, skin fibroblasts, wild type mouse embryonic fibroblasts (MEF) and 
MEF lacking HIF-1α (kindly provided by R. Johnson (14)) were cultured under standard 
normoxic conditions (5% CO2, 74% N2, 21% O2) as described (15). For hypoxic conditions, cells 
were incubated in a hypoxic workstation (InVivo2-400, Ruskinn Technology, Leeds, UK) with 
continuous flow of a gas mixture (either of 1% O2, 5% CO2, 94% N2 or 0.3% O2, 5% CO2, 
94.7% N2). Cells were incubated under hypoxic or normoxic conditions for 48 hours or 4 weeks. 
In some experiments, after 48h of hypoxia, cells were exposed to 4h normoxia. 
 
Gene screening methods 
Two RA synovial fibroblasts (RASF) lines were cultured for 48h under normoxic (20% oxygen) 
and hypoxic (1% oxygen) conditions followed by RNA isolation. Subtractive hybridization was 
performed as described previously (16) with normoxic cDNA as a tester. The Atlas human 1.2 
gene array No. 7850-1 (BD Clontech, Palo Alto, CA, USA) was applied to the cDNA array 
experiment. Data were evaluated by using AtlasImage 2.0 software (Clontech). (17) 
  
SYBR Green and TaqMan Real-time PCR  
The expression of genes were quantified by SYBR Green Real-time PCR or TaqMan Real-time 
PCR as described (15, 18). Sequences of primers and probes are shown in Supplementary Table 
1 and 2. 
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Western blotting 
Nuclear proteins (50 μg/well) isolated from RASF were separated on 15% SDS-PAGE and 
transferred onto PVDF (Bio-Rad, Hercules, CA, USA). Membranes were incubated with rabbit 
anti-Id-2 antibodies (dilution 1/200, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Bands 
were detected by further incubation with peroxidase-conjugated swine anti-rabbit IgGs (dilution 
1/3000, Dako, Glostrup, Denmark) followed by visualization using the ECL system (Amersham, 
Uppsala, Sweden). Control membranes were incubated with anti-nucleoporin p62 antibodies 
(1/500, BD Pharmingen, San Diego, CA, USA) or mouse anti-α-tubulin antibodies (1/1000, 
Sigma). 
 
Immunohistochemistry on paraffin embedded sections 
Human and mouse tissues were prepared as described (19) and stained with (I) rabbit anti- 
human/murine Id-2 antibodies (1 μg/ml, Santa Cruz) or (II) double stained as described 
previously (15) with rabbit anti-human/murine Id-2 antibodies and mouse anti-human vimentin 
Abs (10 g/ml, Dako) or (III) control IgGs, followed by incubation with alkaline phosphatase 
conjugated goat anti-mouse-IgG antibodies (dilution 1/40, Dako), and peroxidase conjugated 
goat anti-rabbit IgGs (dilution 1/1000, Jackson ImmunoResearch Laboratories, West Grove, PA, 
USA). Id-2 positive cells were counted in the lining and sublining layer in four randomly 
selected fields of each section at x 20 magnification.  
 
Immunohistochemistry on frozen sections 
Sections from mouse paws were prepared and mounted onto slides which were incubated with 
biotinylated ELK3-51 antibodies (25 g/ml) or with mouse IgG1 (Dako) for control. Next, 
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sections were incubated with Avidin DH and a biotinylated horseradish peroxidase 
macromolecular complex (ABC system, Vector Laboratories, Burlingame, CA, USA).  
 
Transfection of RASF with Id-2 plasmid, Id-2 lentivirus, HIF-1α siRNA, HIF-2α siRNA 
and Id-2 siRNA 
Id-2 cDNA (Gen Bank number: D13891) was cloned into pcDNA 3.1+ (Invitrogen, Carlsbad, 
CA, USA) and into pLenti6/UbC/V5-Dest (K4990-00, Invitrogen) using Hind III and Xho I 
restriction enzymes (Invitrogen). RASF were transfected with the Id-2 pcDNA or mock plasmid 
(2g/5x105cells) by nucleofection (Amaxa Biosystem, Cologne, Germany) or by Id-2 lentivirus 
particles or control lentivirus particles (105 dilution of the stock) by using Lipofectamine 2000 
(Invitrogen). To obtain stable transfected cells, culture medium was replaced once per week with 
fresh medium containing geneticin (300g/ml) for plasmid transfected cells or with blasticidin 
(1.6 g/ml) for lentivirus transfected cells. Cells were maintained in culture for at least 2-3 
passages (1 month) prior to harvesting. Transfection of RASF with predesigned siRNA targeting 
HIF-1 (Ambion, Huntingdon, UK) or HIF-2 or Id-2 (20) was performed as previously 
described. Briefly, transfection of cells was performed by nucleofection. Six hours after 
transfection, the medium was changed, and the cells were either exposed to hypoxia (1% 
oxygen) or were cultured under normoxic conditions. After 48 hours, RNA was isolated and 
analyzed by Real-time PCR as described (15) (18).  
 
Coculture of RASF with bone marrow cells 
Bone marrow cells from three donors or Saos-2 cells (1 x 106 per well) were seeded in 12 well 
plates on transwell inserts with polyester membranes with 0.4 m pore size (Costar, Cambridge, 
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MA). Bone marrow cells were directly used for the experiments without further manipulation. 
RASF stably transfected with the Id-2 plasmid or mock plasmid were seeded on the plate at a 
density of 8 x 104 per well. Experiments were performed in -MEM as described (21). In some 
experiments, anti-M-CSF (25 g/ml), anti-BMP-2 (25 g/ml), anti-PTHrP (25 mg/ml) or isotype 
controls were added at the beginning of the co-culture. Total RNA from bone marrow cells and 
Saos-2 was isolated as indicated. TRAP staining was performed on day 7 and 14 (21).  
 
TRAP staining 
Membranes from the upper compartment of the transwell system containing bone marrow cells 
and sections from CIA mice (paraffin embedded tissue) were incubated with TRAP substrates 
(Sigma). Bone marrow cells cultured in the presence of RANKL and M-CSF (both 20 ng/ml) 
served as a positive control. As a negative control a membrane without TRAP substrates was 
used. Quantification of osteoclasts was performed by counting TRAP-positive cells (violet 
signal) in four randomly selected fields at x 20 magnification.  
 
Statistical analysis  
Data are shown as mean ± SEM. Statistical analysis was performed using the Mann-Whitney U 
test. 
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Results 
 
The hypoxia marker EF-5 accumulates at sites of synovial invasion into bone in mice with 
collagen-induced arthritis  
The hypoxia marker EF-5 or 0.9% saline was administered to control mice and CIA mice 
(13). Synovial tissue specimens from control mice and CIA mice, both injected with 0.9% saline, 
and control mice injected with EF-5 (Fig. 1A and data not shown) showed no staining after 
incubation with antibodies recognizing EF-5 cell protein adducts. In contrast, all CIA mice 
injected with EF-5 showed strong staining for EF-5 adducts in the synovium (Figs. 1B-E). 
Notably, the strongest EF-5 staining was detected at sites of inflammation (Fig. 1C) and at sites 
of synovial invasion into bone (Figs. 1C-E). CIA tissue specimens incubated with isotype 
controls showed no staining (Figs. 1F). These findings indicate that synovial cells, in particular 
cells in inflammatory infiltrates and cells invading bone, are exposed to reduced oxygen 
concentrations. 
 
Genes regulated by hypoxia in rheumatoid arthritis synovial fibroblasts (RASF) 
To evaluate the molecular effects of the hypoxic environment on RASF, two established 
gene expression-screening methods were used: cDNA array and reverse suppression subtractive 
hybridization. Eleven genes with an induction/suppression ratio >1.4 (after global normalization) 
and with a signal threshold of 200% above background (17) (supplementary Table 3) were 
obtained. Reverse suppression subtractive hybridization method was used to screen for genes 
that had not been fully characterized and were not included in the array. Three additional genes 
were identified as downregulated under hypoxic conditions. DNA sequencing revealed that one 
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of those genes was unknown gene (clone3, cDNA nr FLJ14901 fis), the second one encoded for 
the signal recognition particle 54 (SRP 54) and the third one encoded for ATP synthase. To 
verify the results obtained from the screening, the differential expression of the identified genes 
was evaluated by quantitative Real-time PCR in additional RASF cultures. Six out of 11 genes 
(54%) obtained in cDNA array analysis and 2 out of 3 genes obtained from subtractive 
hybridization were confirmed to be regulated by hypoxia in all tested RASF samples. RASF 
treated with hypoxia (1% oxygen) for 48h expressed significantly higher levels of vascular 
endothelial growth factor (VEGF), Id-2, neurotrophin-3 (NT-3) and insulin like growth factor 
binding protein-3 (IGF-BP3) compared to cells cultured in normoxic conditions (Supplement 
Fig. 1A). In parallel, after 48h of hypoxia the expression of proliferating cell nuclear antigen 
(PCNA), growth-related c-myc-responsive gene (RLC), and FLJ14901 fis cDNA (clone3) was 
significantly decreased in these cells (Supplement Fig. 1B). 
It is likely that synovial fibroblasts in RA joints are constantly exposed to low oxygen 
levels and that 48h of hypoxic condition may not adequately resemble the situation in vivo. 
Therefore, in the next set of experiments, RASF were cultured in hypoxic conditions (1% 
oxygen) for 4 weeks. After this time the expression of VEGF, Id-2, NT-3 and IGF-BP3 was 
increased. Moreover, the expression of Id-2 was significantly higher after 4 weeks of hypoxia 
than after 48h (4.6  1.1 fold versus 2.4  0.2 fold) (Supplement Fig. 1A). Interestingly, 
exposure to long-term hypoxia decreased the expression of SRP 54 and FLJ14901 fis cDNA 
(clone3) compared to 48h exposure (21.9  6.3 fold versus 2.0  0.1 fold) (Supplement 
Fig. 1B). 
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Hypoxia is a potent regulator of Id-2 expression 
Among several genes that were found to be affected by hypoxia in our screening, Id-2 
gene was particularly interesting as it belongs to the family of transcriptional regulators. To 
analyze the effects of hypoxia on all four members of the Id family, SYBR Green Real-time 
PCR, with specific primers, was performed. Hypoxia up-regulated Id-2 expression in both RASF 
(3.24 ± 0.7 fold), and to a lower extend, in OASF (n=5, 2.32 ± 1.1 fold, data not shown). 
Hypoxia did not induce Id-2 expression in primary skin fibroblasts (n=5, 1.21 ± 0.2 fold, data not 
shown). The induction of Id-2 mRNA expression in RASF was dose-dependent (Fig. 2A). On 
the contrary, the expression of other members of the Id family was not affected (Id-1) or only 
slightly modulated by severe hypoxia (Id-3) in RASF (Fig. 2A). Expression of Id-4 was not 
detectable. The induction of Id-2 by hypoxia in RASF was confirmed by immunoblotting, which 
showed a consistent induction of Id-2 protein at 1% oxygen compared to RASF cultured in 
normoxic conditions (Fig. 2B).  To explore the stability of Id-2 expression triggered by hypoxia, 
RASF that had been exposed to hypoxia for 48h were incubated in normoxic conditions for an 
additional 4h. Re-oxygenation decreased the expression of Id-2 by 54±12% compared to the 
levels obtained after 48 h of hypoxia (data not shown).  
Because HIF-1 is the major transcription factor mediating the intracellular effects of 
hypoxia, we next evaluated the role of HIF-1α in the expression of Id-2. Mouse embryonic 
fibroblasts (MEF) deficient for the HIF-1α gene (HIF-1α -/-) as well as wild-type fibroblasts 
(HIF-1α +/+) were cultured under hypoxic and normoxic conditions. As shown in Fig. 2C, 
hypoxia induced the expression of Id-2 in both HIF-1α +/+ as well as in HIF-1α -/- fibroblasts. 
To confirm these data, RASF were transfected with siRNA against HIF-1α and exposed to 
hypoxia. HIF-1 protein was inhibited by HIF-1 specific siRNA but not control siRNA (data 
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not shown). Again, the induction of Id-2 by hypoxia was not affected by inhibition of HIF-1 α 
signaling (Fig. 2D). Altogether, these data suggest that HIF-1α does not play an essential role for 
the hypoxia induced expression of Id-2. Next, we looked at effects of HIF-2α inhibition by 
siRNA. In contrast to HIF-1α, inhibition of HIF-2α decreased the hypoxia-induced induction of 
Id-2 by 54 ± 11% as compared to mock-transfected controls, suggesting that HIF-2α might at 
least partially mediate the hypoxia-induced expression of Id-2 (Fig. 2E) 
 
Id-2 is overexpressed in the synovium of patients with rheumatoid arthritis 
Immunohistochemistry was performed on synovial specimens from RA, OA and trauma 
patients. Id-2 protein was expressed at higher levels in the synovium of RA patients than in the 
synovium from OA and trauma patients (32  13% positive cells in RA synovium, 18  11% in 
OA synovium and 8  3% in normal synovium, p < 0.05) (Figs. 3A-D). Some RA patients 
showed a strong expression of Id-2 in the sublining layer (Fig. 3A), while in others, Id-2 was 
mainly found in the lining layer (Fig. 3B). In addition, Id-2 was expressed in blood vessels of all 
synovial specimens as described before (22). Consistent with the EF-5 data, which suggested that 
hypoxia occurs at sites of inflammation, expression of Id-2 in the sublining layer was most 
abundant at sites of inflammatory infiltrates.  
 
Id-2 is expressed by synovial fibroblasts at sites of synovial invasion into bone 
Based on the EF-5 experiments, which revealed that the lowest oxygen levels were 
present at sites of synovial invasion into bone, we next investigated the expression of Id-2 in 
tissue specimens from RA patients containing the bone-synovium interface. A strong and 
abundant expression of Id-2 protein was found at sites of synovial invasion into bone (Figs. 4A). 
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Similar results were obtained with tissue specimens from CIA mice (Figs. 4B). To characterize 
the cell types expressing Id-2 protein double immunohistochemistry with antibodies against Id-2 
and against vimentin (a marker for fibroblasts) was performed. As shown in Figs. 4C, cells 
expressing Id-2 and invading bone were predominantly fibroblasts. In addition, immunostaining 
for Id-2 and TRAP on subsequent slides indicated that Id-2 positive fibroblasts were located 
closely to bone-degrading TRAP positive osteoclasts. Interestingly, multinuclear, TRAP positive 
osteoclasts also expressed Id-2 (Fig. 4D-E). 
 
Id-2 triggers the expression of genes involved in bone turnover in rheumatoid arthritis 
synovial fibroblasts 
RASF invading bone are a source of numerous factors regulating bone turnover (23, 24). 
To test the hypothesis that Id-2 regulates the expression of these factors at sites of invasion in 
RA patients, we overexpressed Id-2 in RASF (Fig. 5A). Indeed, a large number of genes 
involved in bone turnover were expressed at significantly higher levels in Id-2 transfected RASF 
than in mock-transfected controls (Fig. 5B). The majority of these factors are known to support 
bone degradation and osteoclastogenesis. These include macrophage-colony stimulating factor 
(M-CSF) (23, 25), parathyroid hormone related protein (PTHrP) (26, 27) as well as factors 
having a dual role in bone turnover such as bone morphogenic protein-2 (BMP-2) (28, 29) (Fig. 
5B). In addition, there was also a small, but significant induction of osteoprotegerin (OPG), 
which is known to inhibit osteoclastogenesis (30, 31). Other molecules regulating bone-turnover 
such as cyclooxygenase-2 (COX-2) (32, 33) and metalloproteinase-13 (MMP-13) (34, 35) were 
not changed in Id-2 transfected RASF. The expression of the receptor activator of NF-κB ligand 
(RANKL) (25, 36) was below the detection level of the Real-time PCR in both mock and Id-2 
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transfected RASF. However, the expression of this molecule was easily inducible upon TNF 
stimulation in both mock and Id-2 transfected cells (data not shown). We also investigated 
whether silencing of basal expression of Id-2 in RASF by specific siRNA (Fig. 5C) is able to 
influence the expression of genes involved in bone turnover. Indeed, the most consistent 
downregulation was found for PTHrP, which was inhibited by 49.6 ± 2.8% (p < 0.05) and for 
BMP-2 (Fig. 5D). 
 
Rheumatoid arthritis synovial fibroblasts overexpressing Id-2 promote the induction of 
osteoclastogenesis  
Given that the majority of factors induced by Id-2 in RASF promote osteoclastogenesis, 
we hypothesized that RASF overexpressing Id-2 are able to favor the development of osteoclasts 
from their bone marrow precursors. RASF transfected either with Id-2 or mock vector were 
cocultured with bone marrow cells in a transwell system and the number of TRAP positive 
osteoclasts in the bone marrow cell compartment was determined after 7 and 14 days. Indeed, 
after 7 days of culture TRAP positive, single nuclei, immature osteoclasts appeared in both 
cocultures (Fig. 6A-B) and also in control bone marrow culture stimulated with RANKL and M-
CSF (both 20ng/ml) (Fig. 6C). However, the number of TRAP positive, immature osteoclasts 
strongly increased (Fig. 6A) in coculture with Id-2 transfected RASF compared to bone marrow 
cells cocultured with mock transfected RASF (Fig. 6B) (185 ± 23 versus 49 ± 25, respectively, 
mean ± SEM per 4 randomly selected fields, p  0.05). After 14 days of culture, mature 
multinuclear TRAP positive osteoclasts were present in bone marrow cocultured with Id-2 
transfected RASF (Fig. 6D), but not with mock transfected RASF (Fig. 6E). On the other hand, 
the osteoblast and bone formation marker, alkaline phosphatase (AP), remained unchanged in the 
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bone marrow cell compartment (Fig. 6F). Taken together, these data show that overexpression of 
Id-2 in RASF favors the development of osteoclasts from bone marrow precursors, while not 
affecting the development of osteoblasts.  
Next, we looked at the mechanisms by which the Id-2 overexpressing RASF mediates the 
differentiation of osteoclasts from bone marrow precursors. Interestingly, coculture of Id-2 
transfected RASF with bone marrow cells significantly increased the expression of the pro-
osteoclastogenic protein RANKL in the bone marrow compartment as compared to mock-
transfected RASF (Fig. 6F). In parallel, there was a significant downregulation of the RANKL 
inhibitor OPG in the bone marrow compartment upon coculture with Id-2 transfected RASF 
(Fig. 6F). In addition, the effect of Id-2 overexpressing RASF on RANKL/OPG ratio in 
osteoblast cells was confirmed by coculture of Id-2 and mock transfected RASF with the 
osteoblast-like cell line Saos-2 in a transwell system. Indeed, Saos-2 cell cocultured with RASF 
overexpressing Id-2 showed an upregulation of RANKL and, in parallel, downregulation of OPG 
expression compared to cells cultured with mock RASF (Supplement Fig. 2A).  Since a similar 
effect on osteoblasts was obtained with cancer cells overexpressing PTHrP (27) we hypothesized 
that PTHrP might be a crucial mediator of the Id-2 induced osteoclastogenesis. Indeed, the 
development of TRAP-positive osteoclasts was strongly inhibited by adding anti-PTHrP 
antibodies (Supplement Fig. 2B) in coculture of RASF with bone marrow cells.  
In addition, exposure of RASF to 1% hypoxia for 48h induced PTHrP expression by 2.7 
± 0.4 (p < 0.05) compared to normoxic controls. This indicates that hypoxia, which triggers Id-2, 
is able to induce the Id-2 downstream molecule PTHrP in RASF.  
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Discussion 
Evidence from animal studies as well as indirect evidence from human studies suggest 
that the RA synovium is hypoxic due to inflammation and synovial hyperplasia (1, 4, 37). Using 
the hypoxia marker EF-5, we were able to show the distribution of hypoxic areas in arthritic 
joints. Interestingly, hypoxic cells were found mostly at sites of synovial invasion into bone. The 
invasion of synovial cells into cartilage and bone is the anatomical prerequisite for local erosion 
and destruction of joints, which is the most characteristic feature of RA. Notably, the avascular 
cartilage and the mineralized bone themselves are hypoxic tissues (38, 39). Thus, our data 
provide the evidence that during the invasion of synovial cells into cartilage and bone, these cells 
are exposed to an increasing level of hypoxia.  
In agreement with previous studies, hypoxic cells were also found in inflammatory 
infiltrates in the synovium (40-42) These findings are an important confirmation for the 
landmark studies performed by Cramer et al (4), who showed that the hypoxia responsive 
transcription factor HIF-1α is essential for the initiation and perpetuation of inflammatory 
responses driven by myeloid-lineage cells. Recently, Hamada et al. further supported that 
concept by showing that hypoxia triggers a release of pro-inflammatory protein HMGB-1 from 
RASF  (41).  
This study and the previous data (37, 41, 42) showing that cells in the inflamed synovium 
are exposed to severely reduced oxygen levels have a direct impact on virtually all in vitro 
studies relevant to joint destruction and inflammation in RA. Thus, cell culture studies performed 
under normoxic conditions clearly do not reflect the hypoxic situation occurring in vivo in RA 
patients. Indeed, the influence of hypoxia-driven pathways has not been taken into account in the 
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majority of in vitro experiments in the past. In our screening experiment series we were able to 
identify a number of genes induced by hypoxia in synovial fibroblasts.  
The inhibitor of differentiation-2 (Id-2) was the most intriguing finding because of its role 
in the regulation of transcription. We demonstrated that hypoxia strongly up-regulates the 
expression of Id-2 in RASF but not in skin fibroblasts. The selective induction of Id-2 in RASF 
suggests that this protein might have a specific role in the response of synovial fibroblasts to the 
hypoxic environment which occurs in RA synovium. Using HIF-1α-/- MEF, as well as HIF-1α 
silencing in RASF, we showed that hypoxia is able to induce the expression of Id-2 
independently of HIF-1α signaling. In contrast, we observed a partial inhibition of Id-2 
expression in cells transected with HIF-2 siRNA suggesting that that member of HIF family 
might be, at least partially, involved in hypoxia induced Id-2 expression in RASF. The molecular 
mechanisms of Id-2 induction by hypoxia might be cell-specific and the HIF-1α -independent 
induction might be unique for fibroblasts (43).  
The in vivo relevance of these experiments was confirmed by our immunohistochemistry 
studies showing that Id-2 was expressed at higher amounts in synovial tissues of RA patients 
than either in OA synovium or normal synovium.  
One of the most interesting findings of our study was the strong expression of Id-2 in 
RASF at sites of synovial invasion into bone in both human RA tissues as well as in CIA mice. 
The co-expression of the hypoxia marker EF-5 and Id-2 at sites of invasion indicates that 
hypoxia is indeed a potent inducer of Id-2 in vivo. Based on the observation that Id-2 was 
expressed by fibroblasts invading bone and in close proximity to TRAP positive osteoclasts, we 
hypothesized that Id-2 contributes to bone degradation. Indeed, we found that overexpression of 
Id-2 in RASF triggered the expression of several factors promoting osteoclastogenesis by 
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stimulating the differentiation of osteoclasts such as M-CSF (25) and PTHrP (27). In addition, 
BMP-2, which was also found to be induced by Id-2 in RASF, has a dual role in bone turnover 
and can be a potent inducer of osteoclast differentiation and survival in the presence of M-CSF 
or RANKL (29). Most interestingly, PTHrP was not only induced by Id-2 overexpression, but 
also directly by hypoxia and reversely reduced upon Id-2 silencing in RASF, indicating that this 
factor might be direct mediator of Id-2 responses.  
The biological relevance of the potent osteoclastogenesis-promoting effects of RASF 
overexpressing Id-2 has been proven by the coculture assays of Id-2 transfected RASF with bone 
marrow cells. The development of osteoclasts from bone marrow precursor cells was strongly 
increased in the presence of Id-2 overexpressing RASF compared to controls, while the 
formation of osteoblasts remained unchanged. Thus, the small induction of OPG in RASF 
overexpressing Id-2 was not biologically meaningful and its inhibitory effect was apparently 
overcome by the stronger effects of the several factors promoting osteoclastogenesis. In addition, 
in the cocultures of Id-2 overexpressing RASF with bone marrow cells or osteoblasts, we 
observed an enhanced expression of RANKL accompanied by a decreased expression of OPG by 
bone marrow stromal cells or osteoblasts. These data suggest that the osteoclastogenesis 
promoting effects of RASF overexpressing Id-2 is mediated via changing the ratio of RANKL to 
OPG in the stromal cells. Interestingly, PTHrP, which we identified as an important downstream 
molecule of Id-2 in RASF, has been shown to favor the development of osteoclasts by increasing 
the expression ratio of RANKL to OPG in stromal cells (27). Indeed, in our coculture 
experiments, neutralization of PTHrP inhibited osteoclast development. Moreover, the PTHrP 
gene promoter contains functional E-box-like elements (44) as well as Ets binding sites (45) that  
 19
can be regulated by Id family members. Thus, these data indicate that PTHrP might mediate, at 
least partially, the Id-2 induced osteoclastogenesis.  
It has to be emphasized that the effect of Id-2 on cell-differentiation often depends on the 
cell-type and origin of cells (6-10, 46). Thus, while this study shows that Id-2 promotes the 
synovial fibroblast-dependent osteoclastogenesis in rheumatoid arthritis, the role of Id-2 in 
osteoclasts of RA synovium requires further investigation. Recently, it has been shown that Id 
family members can function as negative regulators of RANKL induced osteoclast 
differentiation from bone marrow precursors in vitro. However, that inhibition could be 
overcome by high dose of RANKL or the presence of stromal cells (47). 
In summary, we demonstrated that synovial cells are exposed to reduced oxygen levels in 
inflammatory infiltrates, mostly at sites of synovial invasion into bone in rheumatoid arthritis. 
Differential screening experiments and confirmation by Real-time PCR and immunoblotting 
showed that Id-2 is consistently induced by hypoxia. Id-2 was upregulated in synovial biopsies 
of patients with RA, and was particularly expressed by synovial fibroblasts at sites of synovial 
invasion into bone. Overexpression of Id-2 in RASF induced the expression of factors promoting 
osteoclastogenesis and strongly stimulated the differentiation of osteoclasts from bone marrow 
precursors. Taken together, our data show that Id-2 induced by hypoxia may contribute to joint 
destruction in patients with RA by promoting synovial fibroblast-dependent osteoclastogenesis.  
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Figure legends 
 
Figure 1: The hypoxia marker EF-5 accumulates in the synovium of CIA mice 
Figure 1 A-F, Immunohistochemistry with ELK3-51 antibodies to detect EF-5 cell protein 
adducts. Sections of ankle joints in hind paws are shown. Figure 1A, Section from healthy 
control mouse. Figure 1B-E, Sections from CIA mice showing strong accumulation of EF5 at 
sites of inflammation (C, enlarged picture, open arrows, brown signal) at sites of synovial 
invasion into bone (closed arrows) (Fig. C-E). Figure 1F, Section from CIA mouse incubated 
with isotype matched antibodies for control. The stainings are representative for four CIA mice 
and three control mice. A-B original magnification, x 10; C-D, F original magnification, x 25; E 
original magnification x 40. B, bone; S, synovium; C, cartilage. 
 
Figure 2: Hypoxia induces the expression of Id-2  
Figure 2A, Hypoxia induces the expression of Id-2 mRNA. Rheumatoid arthritis synovial 
fibroblasts (RASF, n=5) were cultured in 21%, 1% or 0.3% oxygen for 48h followed by total 
RNA extraction and SYBR Green Real-time PCR. Values are the mean fold change ± SEM 
compared to normoxic controls of 3 independent experiments. *p0.05, RASF treated with 1% 
or 0.3% oxygen versus RASF treated with 21% oxygen. Figure 2B, Hypoxia increases Id-2 
protein. RASF were cultured as described in Figure 2A followed by protein isolation and 
Western blot for Id-2 and nucleoporin p62 as a loading control. The Western blot is 
representative of two independent experiments. Figure 2C, Hypoxia induces the expression of 
Id-2 independently of HIF-1αsignaling in mouse embryonic fibroblasts (MEF). HIF-1α+/+ MEF 
and HIF-1α-/- MEF were treated as described in Figure 2A. Values are the mean ± SEM of three 
independent experiments. *p0.05, MEF cultured in 21% oxygen versus MEF cultured in 1% 
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oxygen. Figure 2D, Hypoxia induces the expression of Id-2 independently of HIF-1α in RASF 
Figure 2E, Expression of Id-2 triggered by hypoxia is partially mediated by HIF-2. *p0.05, 
RASF cultured in 21% oxygen versus RASF cultured in 1% oxygen. 
 
Figure 3: Id-2 is overexpressed in rheumatoid arthritis synovium 
Figures 3A-B, RA synovial tissues incubated with anti-Id-2 antibodies showing strong 
expression of Id-2 in the sublining layer (A) and in the lining layer (B, open arrows). Figure 3C, 
Osteoarthritis synovial tissue incubated with anti-Id-2 antibodies showing that the expression of 
Id-2 protein is limited to blood vessels (brown signal, closed arrows). Figure 3D, RA synovial 
tissue incubated with control IgGs. Original magnification x 20; L, lining layer; SBL, sublining 
layer.  
 
Figure 4: Id-2 is expressed by synovial fibroblasts at sites of synovial invasion into bone. 
Figure 4A and D, RA synovial tissue incubated with anti- Id-2 antibodies showing strong 
expression of Id-2 at sites of invasion into bone (brown signal). Figure 4B, Section of synovial 
tissue from CIA mouse incubated with anti- Id-2 antibodies showing strong expression of Id-2 at 
sites of invasion into bone. Figure 4C, RA tissue specimen stained with anti-Id-2 antibodies 
(blue signal) and anti-vimentin antibodies (red signal). Figure 4E, RA synovial tissue stained for 
TRAP (red signal). SF, synovial fibroblasts; OC, osteoclasts; S, synovium; B, bone. Bottom left 
corner inserts at A-C represent control tissue incubated with appropriate IgGs. Data are 
representative of 3 RA patients and 3 CIA mice with similar results. Original magnification x 20. 
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Figure 5: Id-2 triggers the expression of genes involved in bone turnover by rheumatoid 
arthritis synovial fibroblasts.  
Figure 5A, RASF transfected with Id-2 expressed increased levels of Id-2 protein. The Western 
blot for Id-2 and -tubulin is representative of three independent experiments with similar 
results. Figure 5B, Overproduction of Id-2 in RASF triggers the expression of M-CSF, PTHrP, 
BMP-2 and OPG. Total RNA from transfected RASF (n=3, 5 clones) was isolated and Real-time 
PCR was performed. Data are expressed as mean fold increase ± SEM compared to mock 
transfected cells of three independent experiments, *p0.05, Id-2 versus mock transfected cells. 
Figure 5C, Decreased levels of Id-2 protein in RASF transfected with Id-2 siRNA. RASF were 
transfected with control siRNA or Id-2 siRNA, cultured for 48 followed by Western blotting 
with Id-2 and -tubulin antibodies. Figure 5D, Inhibition of Id-2 in RASF leads to 
downregulation of the expression of PTHrP and BMP-2. RASF (n=3) were transfected with Id-2 
siRNA or control siRNA. 48h later, total RNA was isolated and Real-time PCR was performed. 
Data are expressed as mean (% of control siRNA transfected control) ± SEM of two independent 
experiments.*p0.05, Id-2 siRNA versus control siRNA transfected cells. 
 
Figure 6: Coculture of Id-2 transfected rheumatoid arthritis synovial fibroblasts (RASF) 
with bone marrow cells promotes the development of osteoclasts 
Figure 6 A-B, TRAP staining of bone marrow cells (donors, n=3) cocultured with Id-2 
overexpressing RASF (n=3) (A) or mock transfected RASF (n=3) (B) for 7 days. C, Bone 
marrow cells cultured in the presence of RANKL and M-CSF (both 20ng/ml) for 7 days. Bottom 
left corner insert represents control not stained with TRAP substrates. D-E, TRAP staining of 
bone marrow cells cocultured with Id-2 overexpressing RASF (n=3) (D) or mock transfected 
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RASF (n=3) (E) for 14 days. *p0.05, number of osteoclasts (mean ± SEM of two independent 
experiments) in cocultures of bone marrow cells with Id-2 transfected RASF versus mock 
transfected RASF. Blue staining indicates nuclei; violet signal indicates TRAP expression. 
Original magnification x 20. Figure 6F, Coculture of Id-2 transfected RASF with bone marrow 
cells increases the expression of RANKL in bone marrow cells. RNA from bone marrow cells 
was isolated on day 4 of coculture and SYBR Green Real-time PCR for AP and TaqMan Real-
time PCR for RANKL and OPG were performed. Data are expressed as mean fold change ± 
SEM compared to mock-transfected cells. *p0.04 Id-2 transfected RASF versus mock-
transfected cells. 
 
 
